BR0013353A - Combinação de substância ativa com clonidina - Google Patents
Combinação de substância ativa com clonidinaInfo
- Publication number
- BR0013353A BR0013353A BR0013353-1A BR0013353A BR0013353A BR 0013353 A BR0013353 A BR 0013353A BR 0013353 A BR0013353 A BR 0013353A BR 0013353 A BR0013353 A BR 0013353A
- Authority
- BR
- Brazil
- Prior art keywords
- clonidine
- combination
- active substance
- pramipexole
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMBINAçãO DE SUBSTâNCIA ATIVA COM CLONIDINA". A invenção refere-se a uma combinação de substâncias ativas consistindo em clonidina e pramipexol para o tratamento da Síndrome da Perna Inquieta (Restless Leg Syndrome).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19938825A DE19938825A1 (de) | 1999-08-19 | 1999-08-19 | Wirkstoffkombination mit Clonidin |
PCT/EP2000/007718 WO2001013902A2 (de) | 1999-08-19 | 2000-08-09 | Wirkstoffkombination enthaltend clonidin und pramipexol |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0013353A true BR0013353A (pt) | 2002-04-23 |
Family
ID=7918574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0013353-1A Pending BR0013353A (pt) | 1999-08-19 | 2000-08-09 | Combinação de substância ativa com clonidina |
Country Status (19)
Country | Link |
---|---|
US (1) | US20020010201A1 (pt) |
EP (1) | EP1210081A2 (pt) |
JP (1) | JP2003507420A (pt) |
KR (1) | KR20020060163A (pt) |
AR (1) | AR025330A1 (pt) |
AU (1) | AU6440600A (pt) |
BR (1) | BR0013353A (pt) |
CA (1) | CA2376606A1 (pt) |
CO (1) | CO5200840A1 (pt) |
CZ (1) | CZ2002515A3 (pt) |
DE (1) | DE19938825A1 (pt) |
IL (1) | IL147741A0 (pt) |
MX (1) | MXPA02001138A (pt) |
NO (1) | NO20020793L (pt) |
PE (1) | PE20010642A1 (pt) |
PL (1) | PL353358A1 (pt) |
TR (1) | TR200200449T2 (pt) |
UY (1) | UY26293A1 (pt) |
WO (1) | WO2001013902A2 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
RU2004121177A (ru) | 2001-12-11 | 2005-03-10 | Юниверсити Оф Вирджиния Пэйтент Фаундейшн (Us) | Применение прамипексола для лечения бокового амитрофического склероза |
US20040048779A1 (en) * | 2002-05-06 | 2004-03-11 | Erwin Schollmayer | Use of rotigotine for treating the restless leg syndrome |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
ES2310258T5 (es) | 2002-08-30 | 2012-05-31 | Kyowa Hakko Kogyo Co., Ltd. | Antagonistas de los receptores de adenosina A2A para tratar el síndrome de piernas inquietas o mioclono nocturno |
DE60204229T2 (de) * | 2002-12-02 | 2006-02-02 | Schwarz Pharma Ag | Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese |
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
CN101448498B (zh) | 2006-05-16 | 2011-04-27 | 诺普神经科学股份有限公司 | R(+)和s(-)普拉克索的组合物以及使用该组合物的方法 |
WO2008009664A2 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
US8519148B2 (en) | 2007-03-14 | 2013-08-27 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
EP1987815A1 (en) * | 2007-05-04 | 2008-11-05 | Schwarz Pharma Ag | Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
CN102186350A (zh) | 2008-08-19 | 2011-09-14 | 诺普神经科学股份有限公司 | 使用(r)-普拉克索的组合物与方法 |
US9512096B2 (en) | 2011-12-22 | 2016-12-06 | Knopp Biosciences, LLP | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
CA2896055C (en) * | 2012-12-28 | 2021-02-16 | Noven Pharmaceuticals, Inc. | Compositions and methods for transdermal delivery of amphetamine and clonidine |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
EP3838271A1 (en) | 2013-07-12 | 2021-06-23 | Knopp Biosciences LLC | Treating elevated levels of eosinophils and/or basophils |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
CA2921378A1 (en) | 2013-08-13 | 2015-02-19 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
DK3033081T3 (da) | 2013-08-13 | 2021-05-31 | Knopp Biosciences Llc | Sammensætninger og fremgangsmåder til behandling af kronisk urticaria |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
DE4325491A1 (de) * | 1993-07-29 | 1995-02-02 | Boehringer Ingelheim Kg | Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels |
US6001861A (en) * | 1998-01-16 | 1999-12-14 | Pharmacia & Upjohn Company | Use of pramipexole in the treatment of restless legs syndrome |
DE19701619B4 (de) * | 1997-01-17 | 2007-10-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von Pramipexol zur Behandlung des restless legs syndroms |
AU3490300A (en) * | 1999-03-12 | 2000-10-04 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
-
1999
- 1999-08-19 DE DE19938825A patent/DE19938825A1/de not_active Withdrawn
-
2000
- 2000-08-09 KR KR1020027002149A patent/KR20020060163A/ko not_active Application Discontinuation
- 2000-08-09 JP JP2001518040A patent/JP2003507420A/ja active Pending
- 2000-08-09 CA CA002376606A patent/CA2376606A1/en not_active Abandoned
- 2000-08-09 MX MXPA02001138A patent/MXPA02001138A/es unknown
- 2000-08-09 IL IL14774100A patent/IL147741A0/xx unknown
- 2000-08-09 BR BR0013353-1A patent/BR0013353A/pt active Pending
- 2000-08-09 WO PCT/EP2000/007718 patent/WO2001013902A2/de not_active Application Discontinuation
- 2000-08-09 CZ CZ2002515A patent/CZ2002515A3/cs unknown
- 2000-08-09 PL PL00353358A patent/PL353358A1/xx not_active Application Discontinuation
- 2000-08-09 AU AU64406/00A patent/AU6440600A/en not_active Abandoned
- 2000-08-09 EP EP00951485A patent/EP1210081A2/de not_active Withdrawn
- 2000-08-09 TR TR2002/00449T patent/TR200200449T2/xx unknown
- 2000-08-15 UY UY26293A patent/UY26293A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000836A patent/PE20010642A1/es not_active Application Discontinuation
- 2000-08-18 CO CO00062317A patent/CO5200840A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104292A patent/AR025330A1/es active Pending
-
2001
- 2001-10-04 US US09/970,839 patent/US20020010201A1/en not_active Abandoned
-
2002
- 2002-02-18 NO NO20020793A patent/NO20020793L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001013902A2 (de) | 2001-03-01 |
UY26293A1 (es) | 2001-04-30 |
PE20010642A1 (es) | 2001-06-08 |
AR025330A1 (es) | 2002-11-20 |
NO20020793D0 (no) | 2002-02-18 |
WO2001013902A3 (de) | 2001-08-23 |
EP1210081A2 (de) | 2002-06-05 |
CO5200840A1 (es) | 2002-09-27 |
CA2376606A1 (en) | 2001-03-01 |
IL147741A0 (en) | 2002-08-14 |
TR200200449T2 (tr) | 2002-08-21 |
CZ2002515A3 (cs) | 2002-05-15 |
MXPA02001138A (es) | 2002-10-31 |
JP2003507420A (ja) | 2003-02-25 |
DE19938825A1 (de) | 2001-04-26 |
PL353358A1 (en) | 2003-11-17 |
AU6440600A (en) | 2001-03-19 |
US20020010201A1 (en) | 2002-01-24 |
NO20020793L (no) | 2002-02-18 |
KR20020060163A (ko) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0013353A (pt) | Combinação de substância ativa com clonidina | |
BR0110573A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto | |
BR0116169A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização dos compostos, processo para o tratamento profilático ou terapêutico de diabetes do tipo ii e processo para a preparação do composto. | |
EA200000994A1 (ru) | Применение кабэрголина при лечении синдрома усталых ног | |
BR0013355A (pt) | Tratamento com droga para a sìndrome da perna inquieta | |
DE60121988D1 (de) | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln | |
BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
CY1110914T1 (el) | Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν | |
ES2194720T3 (es) | Enzimas para el tratamiento de diabetes mellitus tipo i. | |
DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
ES2058725T3 (es) | Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol. | |
DE58901401D1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
BR9709845B1 (pt) | preparaÇço aquosa de insulina, formulaÇço farmacÊutica parenteral, e, processso para aumentar a estabilidade quÍmica de uma preparaÇço de insulina. | |
CY1106319T1 (el) | Τοπικη θepαπεια στη μασταλγια | |
CY1107312T1 (el) | Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
DK261490D0 (da) | New pharmaceutical compound | |
PT1173201E (pt) | Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina | |
RS8504A (en) | Novel cyclohexil sulphones | |
BR0012169A (pt) | Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia | |
NO993360L (no) | Anvendelse av pramipeksol ved behandling av "restless leg"- syndromet | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |